Podcasts about pathology laboratory medicine

This week's episode features an interview with Dr. Jeniffer Dien Bard and Dr. Amy Leber. Dr. Dien Bard is the Director of Microbiology at the Children's Hospital in Los Angeles, California. Dr. Leber works at the Department of Pathology Laboratory Medicine at Nationwide Children's Hospital in Columbus, Ohio. They join the podcast this week to talk about the shortages of Clinical Medical Laboratory Professionals in Microbiology. Why do we have these shortages? What about training programs? How long does training a professional takes? Tune in to this episode to find out. Link to original article: https://doi.org/10.1128/jcm.00241-22Link to certification for laboratory personnel: https://www.ascp.org/content/board-of-certification/get-credentialedLink for accredited programs: https://www.naacls.org/Find-a-Program.aspx

Mary has a fascinating conversation with Dr. Liz Head, Professor, Vice Chair for Research in the Department of Pathology & Laboratory Medicine at the University of California - Irvine, about research into people with Down syndrome and Alzheimers.    Canadian Clinical Trials United States Clinical Trials

In this segment, Beyond the Scope, we speak to pathologists about their pursuits and interests outside of pathology. How can pathologists "get out of the basement"? How can getting IN the basement be a good thing? What does being a Chair have to do with camels? How can YOU help shape the next edition of the Paris System? On this episode of Beyond the Scope, Dr. Sara Jiang (@Sara_Jiang) speaks with Dr. Eva_Wojcik (@Eva_Wojcik), Chair of Pathology & Laboratory Medicine at Loyola University in Chicago, Past President, American Society of Cytopathology, and Founding Chair of the Paris System for Reporting Urinary Cytopathology.  Don't forget to fill out the Paris Survey! Cover art: Dr. Eva Wojcik. Featured public domain music: US Army Blues, BugaBlue

Author: Rachel Beham, PharmD Educational Pearls: Some synthetic cannabinoids have been contaminated with Brodifacoum. Brodifacoum is a Vitamin K antagonist and can present with a severe coagulopathy. Brodifacoum is commonly known as “superwarfarin” and has a very long half life of 120+ days. Check PT/INR in patients with a bleeding diathesis in setting of synthetic cannabinoid use. Treatment is activated charcoal and large doses of Vitamin K (10mg Q6H for months). References: Lipton R.A.; Klass E.M. (1984). "Human ingestion of a 'superwarfarin' rodenticide resulting in a prolonged anticoagulant effect". JAMA. 252: 3004–3005. La Rosa F; Clarke S; Lefkowitz J. B. (1997). "Brodifacoum intoxication with marijuana smoking". Archives of Pathology & Laboratory Medicine. 121: 67–69

Dr. Roy Nambudripad completed his undergraduate and medical school education at the University of California at Irvine.  He then completed a four-year residency in surgical and clinical pathology at UC Irvine Medical Center, which is the field focused on medical and surgical diagnosis.  Subsequently, Roy spent a year training and getting certified in medical acupuncture through the UCLA/Stanford program under the tutelage of Joseph Helms, MD.   He is a member of the American Academy of Medical Acupuncture as well as the Director of Research for the NAR Foundation, an organization focused on researching forms of non-conventional allergy treatment.  In addition, he spent many years training in NAET with his world-renowned mother, Dr. Devi.  He specializes in NAET and medical acupuncture.   His publications have appeared in peer-reviewed medical journals such as Circulation, International Journal of Surgical Pathology, Archives of Pathology & Laboratory Medicine, and Global Advances in Health & Medicine.  In addition, he has presented his research in medicine at professional society meetings and given international talks on NAET.   Roy enjoys spending time with his family and is also studying for law school which he hopes to complete in 2017.  For more information, visit www.naet.com or www.oc-integrative-medicine.com.   

Intalere welcomes Peter H Gilligan PhD Professor of Microbiology-Immunology and Pathology-Laboratory Medicine at the University of North Carolina School of Medicine and the Director of the Clinical Microbiology-Immunology Laboratories at the University of North Carolina Hospitals, for a discussion on Clostridium difficile. Dr. Gilligan will address risk factor for CDiff, who should be tested for CDiff, carriers of CDiff and CDiff as a Hospital Acquired Infection.

Dr. Larry Kaskel welcomes Dr. Evan Stein to Lipid Luminations. Dr. Stein is Professor of Pathology/Laboratory Medicine and Associate Professor of Internal Medicine at the University of Cincinnati. In 1972 Dr. Stein formed the first Lipid Clinic in South Africa. He will be enlightening us about subfractions and how, why and if we should be paying attention to the.